Terms: = Germ cell tumor AND IRF4, LSIRF, 3662, ENSG00000137265, Q15306
49 results:
1. Longitudinal treatment outcomes of recurrent clival chordomas: a single-center retrospective study.
Hong S; Mahajan A; Shinya Y; Laack NN; Link MJ; O'Brien EK; Stokken JK; Janus JR; Ho TP; Choby G; Van Gompel JJ
J Neurosurg; 2024 Apr; 140(4):920-928. PubMed ID: 37856417
[TBL] [Abstract] [Full Text] [Related]
2. Immunogenomic correlates of immune-related adverse events for anti-programmed cell death 1 therapy.
Zhang L; Shi Y; Han X
Front Immunol; 2022; 13():1032221. PubMed ID: 36505471
[TBL] [Abstract] [Full Text] [Related]
3. Mutually exclusive genetic interactions and gene essentiality shape the genomic landscape of primary melanoma.
Birkeälv S; Harland M; Matsuyama LSAS; Rashid M; Mehta I; Laye JP; Haase K; Mell T; Iyer V; Robles-Espinoza CD; McDermott U; van Loo P; Kuijjer ML; Possik PA; Maria Engler SS; Bishop DT; Newton-Bishop J; Adams DJ
J Pathol; 2023 Jan; 259(1):56-68. PubMed ID: 36219477
[TBL] [Abstract] [Full Text] [Related]
4. BATF epigenetically and transcriptionally controls the activation program of regulatory T cells in human tumors.
Itahashi K; Irie T; Yuda J; Kumagai S; Tanegashima T; Lin YT; Watanabe S; Goto Y; Suzuki J; Aokage K; Tsuboi M; Minami Y; Ishii G; Ohe Y; Ise W; Kurosaki T; Suzuki Y; Koyama S; Nishikawa H
Sci Immunol; 2022 Oct; 7(76):eabk0957. PubMed ID: 36206353
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathologic Spectrum of Secondary Solid tumors of the Prostate of Nonurothelial Origin: Multi-institutional Evaluation of 85 Cases.
Acosta AM; Gordetsky JB; Collins K; Osunkoya AO; Sangoi AR; Miyamoto H; Kao CS; Trpkov K; Van Leenders GJLH; Wobker SE; Maclean F; Lal P; Daniel RE; Brimo F; Wasco M; Hirsch MS; Baniak N; Diaz-Perez JA; Cornejo KM; Choy B; Mehra R; Williamson SR; Epstein JI; Matoso A
Am J Surg Pathol; 2022 Sep; 46(9):1269-1276. PubMed ID: 35900850
[TBL] [Abstract] [Full Text] [Related]
6. FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease-Associated tumors.
Fallah J; Brave MH; Weinstock C; Mehta GU; Bradford D; Gittleman H; Bloomquist EW; Charlab R; Hamed SS; Miller CP; Dorff SE; Chambers WA; Mixter BD; Dinin J; Pierce WF; Ricks TK; Tang S; Donoghue M; Pazdur R; Amiri-Kordestani L; Ibrahim A; Beaver JA
Clin Cancer Res; 2022 Nov; 28(22):4843-4848. PubMed ID: 35727604
[TBL] [Abstract] [Full Text] [Related]
7. Inflammatory Bowel Disease Risk Variants Are Associated with an Increased Risk of Skin Cancer.
Cushing KC; Du X; Chen Y; Stetson LC; Kuppa A; Chen VL; Kahlenberg JM; Gudjonsson JE; Vanderwerff B; Higgins PDR; Speliotes EK
Inflamm Bowel Dis; 2022 Nov; 28(11):1667-1676. PubMed ID: 35018451
[TBL] [Abstract] [Full Text] [Related]
8. irf4-activated TEX41 promotes the malignant behaviors of melanoma cells by targeting miR-103a-3p/C1QB axis.
Zheng Y; Zhou W; Li M; Xu R; Zhang S; Liu Y; Cen Y
BMC Cancer; 2021 Dec; 21(1):1339. PubMed ID: 34915882
[TBL] [Abstract] [Full Text] [Related]
9. Association of Melanoma-Risk Variants with Primary Melanoma tumor Prognostic Characteristics and Melanoma-Specific Survival in the GEM Study.
Davari DR; Orlow I; Kanetsky PA; Luo L; Busam KJ; Sharma A; Kricker A; Cust AE; Anton-Culver H; Gruber SB; Gallagher RP; Zanetti R; Rosso S; Sacchetto L; Dwyer T; Gibbs DC; Ollila DW; Begg CB; Berwick M; Thomas NE
Curr Oncol; 2021 Nov; 28(6):4756-4771. PubMed ID: 34898573
[TBL] [Abstract] [Full Text] [Related]
10. SOX10 Regulates Melanoma Immunogenicity through an irf4-IRF1 Axis.
Yokoyama S; Takahashi A; Kikuchi R; Nishibu S; Lo JA; Hejna M; Moon WM; Kato S; Zhou Y; Hodi FS; Song JS; Sakurai H; Fisher DE; Hayakawa Y
Cancer Res; 2021 Dec; 81(24):6131-6141. PubMed ID: 34728538
[TBL] [Abstract] [Full Text] [Related]
11. Different Pigmentation Risk Loci for High-Risk Monosomy 3 and Low-Risk Disomy 3 Uveal Melanomas.
Mobuchon L; Derrien AC; Houy A; Verrier T; Pierron G; Cassoux N; Milder M; Deleuze JF; Boland A; Scelo G; Cancel-Tassin G; Cussenot O; Rodrigues M; Noirel J; Machiela MJ; Stern MH
J Natl Cancer Inst; 2022 Feb; 114(2):302-309. PubMed ID: 34424336
[TBL] [Abstract] [Full Text] [Related]
12. cell-type-specific meQTLs extend melanoma GWAS annotation beyond eQTLs and inform melanocyte gene-regulatory mechanisms.
Zhang T; Choi J; Dilshat R; Einarsdóttir BÓ; Kovacs MA; Xu M; Malasky M; Chowdhury S; Jones K; Bishop DT; Goldstein AM; Iles MM; Landi MT; Law MH; Shi J; Steingrímsson E; Brown KM
Am J Hum Genet; 2021 Sep; 108(9):1631-1646. PubMed ID: 34293285
[TBL] [Abstract] [Full Text] [Related]
13. BATF and irf4 cooperate to counter exhaustion in tumor-infiltrating CAR T cells.
Seo H; González-Avalos E; Zhang W; Ramchandani P; Yang C; Lio CJ; Rao A; Hogan PG
Nat Immunol; 2021 Aug; 22(8):983-995. PubMed ID: 34282330
[TBL] [Abstract] [Full Text] [Related]
14. From the Immune Profile to the Immunoscore: Signatures for Improving Postsurgical Prognostic Prediction of Pancreatic Neuroendocrine tumors.
Wei M; Xu J; Hua J; Meng Q; Liang C; Liu J; Zhang B; Wang W; Yu X; Shi S
Front Immunol; 2021; 12():654660. PubMed ID: 33968055
[TBL] [Abstract] [Full Text] [Related]
15. A genome-wide association study identifies novel gene associations with facial skin wrinkling and mole count in Latin Americans.
Chen Y; André M; Adhikari K; Blin M; Bonfante B; Mendoza-Revilla J; Fuentes-Guajardo M; Palmal S; Chacón-Duque JC; Hurtado M; Villegas V; Granja V; Jaramillo C; Arias W; Lozano RB; Everardo-Martínez P; Gómez-Valdés J; Villamil-Ramírez H; de Cerqueira CCS; Hünemeier T; Ramallo V; Gonzalez-José R; Schüler-Faccini L; Bortolini MC; Acuña-Alonzo V; Canizales-Quinteros S; Gallo C; Poletti G; Bedoya G; Rothhammer F; Balding D; Tobin DJ; Wang S; Faux P; Ruiz-Linares A
Br J Dermatol; 2021 Nov; 185(5):988-998. PubMed ID: 33959940
[TBL] [Abstract] [Full Text] [Related]
16. Interferon regulatory factor transcript levels correlate with clinical outcomes in human glioma.
Lei J; Zhou MH; Zhang FC; Wu K; Liu SW; Niu HQ
Aging (Albany NY); 2021 Apr; 13(8):12086-12098. PubMed ID: 33902005
[TBL] [Abstract] [Full Text] [Related]
17. Inhibition of xCT suppresses the efficacy of anti-PD-1/L1 melanoma treatment through exosomal PD-L1-induced macrophage M2 polarization.
Liu N; Zhang J; Yin M; Liu H; Zhang X; Li J; Yan B; Guo Y; Zhou J; Tao J; Hu S; Chen X; Peng C
Mol Ther; 2021 Jul; 29(7):2321-2334. PubMed ID: 33744468
[TBL] [Abstract] [Full Text] [Related]
18. Influence of germline genetic variants on dermoscopic features of melanoma.
Pozzobon FC; Tell-Marti G; Calbet-Llopart N; Barreiro A; Espinosa N; Potrony M; Alejo B; Podlipnik S; Combalia M; Puig-Butillé JA; Carrera C; Malvehy J; Puig S
Pigment Cell Melanoma Res; 2021 May; 34(3):618-628. PubMed ID: 33342058
[TBL] [Abstract] [Full Text] [Related]
19. Association of Known Melanoma Risk Factors with Primary Melanoma of the Scalp and Neck.
Wood RP; Heyworth JS; McCarthy NS; Mauguen A; Berwick M; Thomas NE; Millward MJ; Anton-Culver H; Cust AE; Dwyer T; Gallagher RP; Gruber SB; Kanetsky PA; Orlow I; Rosso S; Moses EK; Begg CB; Ward SV
Cancer Epidemiol Biomarkers Prev; 2020 Nov; 29(11):2203-2210. PubMed ID: 32856602
[TBL] [Abstract] [Full Text] [Related]
20. Cross-species analysis of enhancer logic using deep learning.
Minnoye L; Taskiran II; Mauduit D; Fazio M; Van Aerschot L; Hulselmans G; Christiaens V; Makhzami S; Seltenhammer M; Karras P; Primot A; Cadieu E; van Rooijen E; Marine JC; Egidy G; Ghanem GE; Zon L; Wouters J; Aerts S
Genome Res; 2020 Dec; 30(12):1815-1834. PubMed ID: 32732264
[TBL] [Abstract] [Full Text] [Related]
[Next]
